CENTOGENE

Join CENTOGENE's Ian Rentsch, Eric Mertz, Ombretta Palucci, and Ana de Lillo, PhD at the 2024 International Society for Pharmacoepidemiology (ISPE) Annual Meeting to learn more about how we can work together to deliver date-driven, life-changing answers for patients around the world. Connect with the team today and arrange a meeting to find out more about our Pharma suite of services, from discovery and early clinical research, through drug development, and beyond. #ISPEAnnual2024 #CENTOGENE #Pharmacoepidemiology #RWE #RWD #Pharma #RareDisease #Neurodegenerative #Event #Conference #Networking #Berlin #Germany

CENTOGENE's Chief Medical and Genomic Officer Peter Bauer recently sat down with Clinical Trials Arena to discuss the importance of genetic testing in Parkinson’s disease patient care. To hear more from Peter and how the latest data from our ROPAD Study demonstrates that identification of gene variants plays a key role in accelerating potential treatment options, visit: https://lnkd.in/e6AXgy5k #Parkinsons #Research #Science #Publication #Collaboration #Innovation #Genetics #ROPAD #CENTOGENE

MAGC 2024 is just around the corner! Join the CENTOGENE team at the Annual Educational Conference of the Michigan Association of Genetic Counselors this Friday, August 16th.   Let’s meet in Lansing! Connect with our USA representatives Kim Slamkova and Elizabeth Couchon to arrange a meeting and learn more about how we are accelerating the diagnosis of rare and neurodegenerative diseases. #Multiomics #MOx #MultiomicRevolution #Genetics #Diagnostics #Conference #MAGC2024 #Event #Networking #Michigan #USA

Did you know last week scientists around the world celebrated RNA Day? August 1st was chosen as World RNA Day due to the pun between August 1st and AUG (Adenine, Uracil, and Guanine), a triple sequence of RNA (called a codon) that initiates protein synthesis by the cell.   CENTOGENE's multiomic approach integrates different data sets (omics) in a single test, including via RNA sequencing! #MOxMonday #RNA #RNADay #Transcriptomics #Multiomics #RareDisease #Patient #Innovation

For #Investors and #Media CENTOGENE is excited to announce our latest scientific publication in Brain journal – revealing 15% of Parkinson’s disease cases are linked to genetic factors. To read more about how this data from the largest international genetic Parkinson’s patient cohort shows approximately 90% of these genetically confirmed patients had variants in the LRRK2 or GBA1 genes, making these individuals potential candidates to be included in gene-targeted trials, visit: https://bit.ly/3WMHM8L Oxford University Press #Parkinsons #Research #Science #Publication #Collaboration #Innovation #Genetics #Diagnostics #Pharma #ROPAD #CENTOGENE

Thank you Tinatin (Tika) Tkemaladze for your years of passion, persistence, and a purpose that is much bigger than all of us. Together, we can improve health outcomes for a better tomorrow. At CENTOGENE, we team up with physicians, researchers, and institutions around the world, because we have a shared mission – to diagnose and accelerate potential treatment options for our patients. We believe that everyone deserves access to life-changing answers, powered by the most complete clinical picture to guide medical decisions. #RareIsMany #RareDisease #Patients #Physicians #Partnership #Collaboration #Diagnostics #Multiomics #Treatment #Science #Research Nature Magazine

For #Investors and #Media Critical Path Institute (C-Path) and CENTOGENE are pleased to announce the signing of a Memorandum of Understanding (MOU) to advance drug development for lysosomal diseases (LDs) and improve the quality of life for those impacted by these conditions. To learn more about our shared vision and we are joining forces to transform real-world data into life-saving therapeutics for patients around the world, visit: https://lnkd.in/eBZFU2QQ #CPath #CENTOGENE #Collaboration #Research #DrugDevelopment #LysosomalDiseases #Pharma #Patients

Less than 24 hours to go until the Drug Information Association (DIA) 2024 Global Annual Meeting in San Diego, California, kicks off! Connect with Ian Rentsch, Mario D'Alessandro, Daniel Kimball, and Pierre ENGEL June 16-20 to learn more about how we can work together to discover, develop, and commercialize treatments for rare and neurodegenerative diseases. Make sure to catch our poster presentation on June 18, as Pierre presents insights from the largest study to date in hereditary transthyretin-related amyloidosis patients in Germany: https://lnkd.in/eme_zb8X We look forward to connecting with industry leaders, sharing knowledge, and building new partnerships! #DIA2024 #CENTOGENE #RareDisease #Neurodegenerative #Pharma #Innovation #Healthcare #Networking #Conference #SanDiego #USA

Today may be the last day of ESHG, but the CENTOGENE team is energized and can't wait to connect! Join us onsite to learn more about how we can work together to deliver data-driven, life-changing answers to patients around the world. Dr. Alexandros Kouskoukis, MSc, Esteban Czwan, Martin Shumanov, Eduard Garcia, DVM, MMD, Dr. Holger Stephan (PhD), Rifat Cenk MISIRLIOĞLU DVM, MBA C., Jorge Pinto Basto, Aida Bertoli Avella, Alejandra Reyes, krishna kumar kandaswamy, Catarina Pereira, Kornélia Tripolszki, Carolin Meier, Daniel L. Polla, Dr. Moneeb Othman, Ph.D, Dr.rer.nat. Boodor Al-Kawlani, Ligia S Almeida, Maria Kammerer, Anelise Roosch, Daniela Teixeira, Dr. Maria Piques, Eleni Perrakis, PhD #ESHG2024 #CENTOGENE #CNTG #RareDisease #Neurodegenerative #Multiomics #Conference #Event #Networking #Berlin #Germany

Here we come ESHG Day 3! Thanks to everyone who has stopped by our booth and connected with the CENTOGENE team. We have loved exchanging the latest scientific insights and advances in healthcare to deliver life-changing answers to patients around the world! Join us today at booth #334 and check out our poster presentations Dr. Alexandros Kouskoukis, MSc, Martin Shumanov, Eduard Garcia, DVM, MMD, Dr. Holger Stephan (PhD), Rifat Cenk MISIRLIOĞLU DVM, MBA C., Jorge Pinto Basto, Aida Bertoli Avella, Alejandra Reyes, krishna kumar kandaswamy, Catarina Pereira, Kornélia Tripolszki, Carolin Meier, Daniel L. Polla, Dr. Moneeb Othman, Ph.D, Dr.rer.nat. Boodor Al-Kawlani, Ligia S Almeida, Maria Kammerer, Anelise Roosch, Daniela Teixeira, Dr. Maria Piques #ESHG2024 #CENTOGENE #CNTG #RareDisease #Neurodegenerative #Multiomics #Conference #Event #Networking #Berlin #Germany